Recla, James Ervic .

HRN: 07-64-06  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2026
CEFUROXIME 750MG (VIAL)
08/10/2026
08/16/2026
IVT
750mg
Q8H
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines